Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson’s Disease Model
Marta García-Gómara(Navarre Institute of Health Research), Ana García‐Osta(Navarre Institute of Health Research)
Cited by 13
Related Papers
Phenylbutyrate Ameliorates Cognitive Deficit and Reduces Tau Pathology in an Alzheimer's Disease Mouse Model
|Neuropsychopharmacology|2009|413
Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease
|British Journal of Pharmacology|2011|210
A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer’s Disease Mice
|Neuropsychopharmacology|2016|104
MuSK Expressed in the Brain Mediates Cholinergic Responses, Synaptic Plasticity, and Memory Formation
|Journal of Neuroscience|2006|94